250 related articles for article (PubMed ID: 24400911)
21. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
22. Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.
Iqbal J; Shen Y; Huang X; Liu Y; Wake L; Liu C; Deffenbacher K; Lachel CM; Wang C; Rohr J; Guo S; Smith LM; Wright G; Bhagavathi S; Dybkaer K; Fu K; Greiner TC; Vose JM; Jaffe E; Rimsza L; Rosenwald A; Ott G; Delabie J; Campo E; Braziel RM; Cook JR; Tubbs RR; Armitage JO; Weisenburger DD; Staudt LM; Gascoyne RD; McKeithan TW; Chan WC
Blood; 2015 Feb; 125(7):1137-45. PubMed ID: 25498913
[TBL] [Abstract][Full Text] [Related]
23. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
[TBL] [Abstract][Full Text] [Related]
24. The tumor suppressive role of inhibin βA in diffuse large B-cell lymphoma.
Jiang L; Si T; Yu M; Zeng X; Morse HC; Lu Y; Ouyang G; Zhou JX
Leuk Lymphoma; 2018 May; 59(5):1202-1212. PubMed ID: 28877610
[TBL] [Abstract][Full Text] [Related]
25. MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1.
Sun JR; Zhang X; Zhang Y
Cell Mol Biol Lett; 2019; 24():68. PubMed ID: 31844419
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-181a Inhibits Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Progression by Repressing
Zhu D; Fang C; He W; Wu C; Li X; Wu J
J Oncol; 2019; 2019():9832956. PubMed ID: 31662757
[TBL] [Abstract][Full Text] [Related]
27. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
29. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
Iqbal J; Sanger WG; Horsman DE; Rosenwald A; Pickering DL; Dave B; Dave S; Xiao L; Cao K; Zhu Q; Sherman S; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Ott G; Müller-Hermelink HK; Delabie J; Braziel RM; Jaffe ES; Campo E; Lynch JC; Connors JM; Vose JM; Armitage JO; Grogan TM; Staudt LM; Chan WC
Am J Pathol; 2004 Jul; 165(1):159-66. PubMed ID: 15215171
[TBL] [Abstract][Full Text] [Related]
30. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
[TBL] [Abstract][Full Text] [Related]
31. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
Liu YH; Xu FP; Zhuang HG; Lai KC; Xie D; Luo DL; Li L; Luo XL; Xu J; Zhang MH; Zhang F; Li HM
Hum Pathol; 2008 Jun; 39(6):875-84. PubMed ID: 18440593
[TBL] [Abstract][Full Text] [Related]
33. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
Deng L; Jiang L; Tseng KF; Liu Y; Zhang X; Dong R; Lu Z; Wang X
Cancer Biomark; 2018; 23(2):157-164. PubMed ID: 30175971
[TBL] [Abstract][Full Text] [Related]
34. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
35. Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma.
Ahmadvand M; Eskandari M; Pashaiefar H; Yaghmaie M; Manoochehrabadi S; Khakpour G; Sheikhsaran F; Montazer Zohour M
Leuk Res; 2018 Jul; 70():45-48. PubMed ID: 29807272
[TBL] [Abstract][Full Text] [Related]
36. Diffuse large B-cell lymphoma.
Li S; Young KH; Medeiros LJ
Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
[TBL] [Abstract][Full Text] [Related]
37. Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models.
Beheshti A; Stevenson K; Vanderburg C; Ravi D; McDonald JT; Christie AL; Shigemori K; Jester H; Weinstock DM; Evens AM
Sci Rep; 2019 Nov; 9(1):17161. PubMed ID: 31748664
[TBL] [Abstract][Full Text] [Related]
38. Germinal center B-cell-like versus non-germinal center B-cell-like as important prognostic factor for localized nodal DLBCL.
Habara T; Sato Y; Takata K; Iwaki N; Okumura H; Sonobe H; Tanaka T; Orita Y; Abd Al-Kader L; Asano N; Ennishi D; Yoshino T
J Clin Exp Hematop; 2012; 52(2):91-9. PubMed ID: 23037624
[TBL] [Abstract][Full Text] [Related]
39. Angiomirs expression profiling in diffuse large B-Cell lymphoma.
Borges NM; do Vale Elias M; Fook-Alves VL; Andrade TA; de Conti ML; Macedo MP; Begnami MD; Campos AH; Etto LY; Bortoluzzo AB; Alves AC; Young KH; Colleoni GW
Oncotarget; 2016 Jan; 7(4):4806-16. PubMed ID: 26683099
[TBL] [Abstract][Full Text] [Related]
40. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
